Furthermore, Smad4 is a tumour suppressor protein and malignant enterocytes commonly develop inactivating mutations in its gene during the late CRC stages, and loss of Smad4 protein has been linked with RSC and poor prognosis [5, 6]. Here, SMAD4 is linked to colorectal carcinoma.